Portfolio Lab

National Healthcare Corp

  • Stock
  • Ticker NHC
  • ISIN US6359061008
  • NYSE

Health care · Health care services · USA

$190.77 +1.18%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of National Healthcare Corp since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

NHCGlobal equities (VT)

$10,000 grew to $36,025. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −35.3% in 03/2020, measured from the peak in 01/2020. It took 47 months to get back to the old peak.

1-year return
+52.0%
5-year return p.a.
+25.5%
10-year return p.a.
+13.7%
Volatility p.a.
24.3%
Largest decline
−35.3%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue369374375383387382408408
Operating income2931343033324941
EBITDA4042454245446055
Net income6.132243925364014
Earnings per share0.382.071.522.501.572.272.540.85
Balance sheet
Total assets1,5241,5491,5621,5721,5261,5241,5372,068
Liabilities541541537514452427409937
Equity9801,0051,0221,0531,0691,0911,1221,125
Cash769011113193863967
Long-term debt13012710366330.00.0478
Cash flow
Operating cash flow1339636617634399
Capital expenditure-8.2-6.1-10-9.7-10-9.6-13–
Free cash flow4.63353566.4533199

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2023 at +60.8%, weakest 2020 at −20.7%. 6 of 9 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
5 Nov 2026$0.85
6 Aug 2026$2.54
7 May 2026$2.27
26 Feb 2026$1.57
6 Nov 2025$2.50
7 Aug 2025$1.52
8 May 2025$2.07
28 Feb 2025$0.38
7 Nov 2024$2.73
8 Aug 2024$1.73
9 May 2024$1.69
16 Feb 2024$1.84

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€2.7bn
Market cap in trading currency
$2.99bn
Enterprise value
$3.42bn
P/E
26.4
P/S
1.89
P/B
2.66
EV/Sales
2.16
EV/EBITDA
16.8
Earnings yield
3.8%
FCF yield
7.4%

Results (last four quarters)

Revenue
$1.58bn
Gross profit
–
EBITDA
$204m
Net income
$115m
Earnings per share
$7.23
Revenue per share
$101.14
Revenue growth
+6.6%
Earnings growth
−65.2%

Profitability

Gross margin
–
Operating margin
9.8%
Net margin
7.2%
Return on equity
10.5%
Return on assets
5.5%

Balance sheet and cash flow

Cash
$66.8m
Cash per share
$4.26
Financial debt
$502m
Debt/equity %
45
Current ratio
1.48
Book value per share
$71.81
Operating cash flow
$222m
Free cash flow
$222m

Dividend

Dividend yield
1.37%
Dividend (12 months)
$2.62
Yield (12 months)
1.37%
Payout ratio
36%
Ex-dividend date
30 Sep 2026

Shares and trading

Shares outstanding
15.7m
Volume
100,387
Avg. volume 3 months
122,113
Relative volume
0.8

Price and technicals

Price
$190.77
1 day
+1.2%
52-week high
$247.94
52-week low
$127.36
Distance to 52-week high
−23.1%
Distance to 52-week low
+49.8%
Distance to 50-day line
−13.5%
Distance to 200-day line
−4.0%
RSI (14)
30
Volatility 1M
39.6%

Performance

1 week
−8.3%
1 month
−21.5%
3 months
−16.5%
6 months
−2.7%
YTD
+39.2%
1 year
+51.2%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
30 Sep 2026

Frequently asked questions

How has NHC performed since 11/2016?

$10,000 grew to $36,025 by 20 Nov 2026, which is +13.7% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is NHC?

Volatility was 24.3% per year, measured on monthly returns. The largest decline from a peak was −35.3%, with the low in 03/2020.

How does NHC compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, NHC returned +13.7% at 24.3%. The correlation of monthly returns was 0.29; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

National Healthcare Corp (NHC): Return and risk